Guavy Wire
Earlier in Commodities
All Commodities leads
Taipower Faces NT$160 Billion Fuel Cost Surge Amid Middle East Tensions
Taiwan Power Co (Taipower) is set to incur NT$160 billion (US$4.92 billion) in additional fuel costs this year due to rising natural gas prices amid Middle East tensions. The company’s accumulated losses are expected to reach NT$420 billion, close to the record NT$421.1 billion loss in 2024. Taipower has requested a NT$71.1 billion supplemental budget to cover growing losses, which are attributed to high fuel costs, low electricity rates, and interest expenses from infrastructure borrowing. The government has delayed electricity rate adjustments, with another review scheduled for December.
Natural Gas
Workers’ Party Regrets Indonesia’s Gas Export Cut to Singapore
Natural Gas
U.S. Executives Resign from Alaska Gas Venture Over Alleged Russian Control
Natural Gas
Gold Hits 4000 Floor Amid Fed Rate Hike Fears
Gold
Remittix Plans 300M RTX Burn as Oil Pressures Bitcoin
Oil
Bitcoin Dips Below $80K as Schiff Warns of Further Decline
Copper
Egyptian Swiss Group Targets 15% Export Growth Amid Market Diversification
Wheat
Earlier in Crypto
All Crypto leads
Netanyahu’s Crypto Sanctions Plan Sparks Election Debate in Israel
Israeli Prime Minister Benjamin Netanyahu discussed the possibility of using cryptocurrency to bypass economic sanctions, sparking criticism from opponents who claim he is fearmongering ahead of the election. Netanyahu clarified that his remarks were about contingency planning, not an immediate shift to a crypto economy. The Bank of Israel and a group of economists warned that sanctions could have severe economic consequences, while Netanyahu’s critics accused him of threatening national security and economic stability.
Kraken Begins Token Withdrawal Phase After Trading Halt
BNB
APU
Netanyahu Proposes Crypto to Evade Sanctions Amid Growing Isolation
BTC
US Bitcoin ETFs Rebound with $301 Million Inflow After Two Weeks of Losses
BTC
Bitcoin ETFs Snap Two-Week Losing Streak Amid Late-Week Slide
BTC
ETH
SOL
Latvia to Set Tokenization Rules for Commercial Property in 2027
MEW
Robotos NFT Sees Trading Volume Rise Amid Market Cap Dip
ETH
NFT
Earlier in Forex
All Forex leads
ECB Official Highlights Digital Euro for EU Payment Sovereignty
European Central Bank Executive Board member Piero Cipollone has highlighted the digital euro as crucial for protecting the EU’s sovereignty over payment systems. The digital euro pilot, set for next year, aims to reduce dependency on non-European third parties. Cipollone noted that two-thirds of euro-area card transactions are currently governed by non-European companies, creating a strategic vulnerability. The ECB hopes to finalize the regulation by the end of the year, allowing a formal decision on issuing the digital euro.
EUR
Korean Won Decouples from Stock Market Amid Chip Boom and Volatility
JPY
Burnham Warned of Truss-Style Crisis Over Budget Decisions
GBP
RBNZ set to raise interest rates to combat high inflation
NZD
Christine Lagarde's Elegant Couture Sparks Political Criticism
EUR
Goldberg Advises Against Rate Hike Bet as Market Swings on Inflation Data
USD
Hong Kong pushes for yuan’s bigger role in regional trade
USD
Earlier in Stocks
All Stocks leads
Roche Lung Cancer Drug Divarasib Outperforms Rivals in Study
Roche's experimental lung cancer drug, divarasib, showed superior results in a late-stage study, helping patients live almost six months longer than those treated with Amgen's sotorasib or Bristol-Myers Squibb's adagrasib. The study involved patients with non-small cell lung cancer that had spread due to a genetic mutation after other treatments. Divarasib's performance positions it as a potential blockbuster in the pharmaceutical market.
AMGN
Essential Windows 11 Apps to Keep and Remove
MSFT
Gen Xers Struggle with Retirement Readiness as Financial Insecurity Grows
GS
Google DeepMind prioritizes lifelong learners for AI roles
GOOGL
Amgen's Imdelltra Shows Unprecedented Survival Benefits in Lung Cancer Study
AMGN
Congo launches Ebola vaccine trial amid worsening outbreak
MRK
Amgen-AstraZeneca combo therapy slashes lung cancer death risk by 58%
AMGN